Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Joint | JYNT | Nov 15, 2024 | 11.06 | -1.43 |
The Marygold Companies | MGLD | Nov 15, 2024 | 1.28 | -4.48 |
The ODP | ODP | Nov 15, 2024 | 25.18 | -0.75 |
The OLB Group | OLB | Nov 15, 2024 | 1.89 | +2.16 |
The Oncology Institute | TOI | Nov 15, 2024 | 0.18 | -23.47 |
The ONE Group Hospitality | STKS | Nov 15, 2024 | 3.02 | +1.34 |
The Pennant Group | PNTG | Nov 15, 2024 | 31.43 | -1.47 |
The Real Brokerage | REAX | Nov 15, 2024 | 4.95 | -4.26 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 15, 2024 | 42.98 | +0.12 |
The RealReal | REAL | Nov 15, 2024 | 3.99 | 0.00 |
The RMR Group A | RMR | Nov 15, 2024 | 22.19 | -1.47 |
The Shyft Group | SHYF | Nov 15, 2024 | 13.92 | -1.49 |
The Trade Desk A | TTD | Nov 15, 2024 | 118.15 | -6.14 |
The9 ADR | NCTY | Nov 15, 2024 | 11.14 | -1.42 |
TherapeuticsMD | TXMD | Nov 15, 2024 | 1.40 | -4.11 |
Theratechnologies | THTX | Nov 15, 2024 | 1.18 | -2.48 |
Theravance Biopharma | TBPH | Nov 15, 2024 | 9.52 | -0.52 |
Theriva Biologics | TOVX | Nov 15, 2024 | 1.36 | +0.74 |
Thermo Fisher Scientific | TMO | Nov 15, 2024 | 513.08 | -3.74 |
Thermon Group | THR | Nov 15, 2024 | 29.71 | +0.34 |
Third Coast Bancshares | TCBX | Nov 15, 2024 | 34.58 | -0.26 |
Third Harmonic | THRD | Nov 15, 2024 | 12.15 | -5.81 |
Thomson Reuters | TRI | Nov 15, 2024 | 161.71 | -1.84 |
Thor Industries | THO | Nov 15, 2024 | 109.37 | -0.05 |
Thornburg Income Builder Opportunities Fund | TBLD | Nov 15, 2024 | 16.56 | -0.66 |
Thoughtworks | TWKS | Nov 15, 2024 | 4.47 | 0.00 |
ThredUp A | TDUP | Nov 15, 2024 | 0.92 | -0.58 |
Thryv | THRY | Nov 15, 2024 | 13.73 | -1.86 |
Thumzup Media | TZUP | Nov 15, 2024 | 3.21 | 0.00 |
Thunder Bridge Capital Partners IV SPAC A | THCP | Nov 15, 2024 | 11.11 | -0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.